We are live on ! Find out more
QCOR

QUESTCOR PHARMA INC
QCOR

Delisted

QCOR was delisted on the 14th of August, 2014.

320 hedge funds and large institutions have $6.07B invested in QUESTCOR PHARMA INC in 2014 Q2 according to their latest regulatory filings, with 86 funds opening new positions, 68 increasing their positions, 142 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more funds holding in top 10

Funds holding in top 10: 817 (+9)

50% more capital invested

Capital invested by funds: $4.06B → $6.07B (+$2.01B)

2% more funds holding

Funds holding: 313320 (+7)

9% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 79

52% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 142

79% less call options, than puts

Call options by funds: $349M | Put options by funds: $1.67B

Holders
320
Holders Change
+7
Holders Change %
+2.24%
% of All Funds
9.2%
Holding in Top 10
17
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+112.5%
% of All Funds
0.49%
New
86
Increased
68
Reduced
142
Closed
79
Calls
$349M
Puts
$1.67B
Net Calls
-$1.32B
Net Calls Change
-$1.12B
Name Holding Trade Value Shares
Change
Change in
Stake
Nordea Investment Management
251
Nordea Investment Management
Sweden
$410K +$379K +4,430 New
FA
252
FDx Advisors
Illinois
$406K -$1.03M -12,038 -73%
IFS
253
Ifrah Financial Services
Arkansas
$406K -$3.17K -37 -0.8%
NGA
254
Naples Global Advisors
Florida
$400K
HIMCH
255
Hartford Investment Management Co (HIMCO)
Connecticut
$393K -$86.5K -1,010 -19%
MLICM
256
Metropolitan Life Insurance Company (MetLife)
New York
$390K -$3.17M -37,020 -90%
WJA
257
Williams Jones & Associates
New York
$370K -$343K -4,000 -50%
GF
258
Gabelli Funds
New York
$370K +$343K +4,000 New
VKH
259
Virtu KCG Holdings
New York
$369K +$342K +3,995 New
NG
260
NatWest Group
United Kingdom
$362K +$335K +3,914 New
AG
261
Algert Global
California
$361K -$927K -10,830 -74%
TC
262
TradeLink Capital
Illinois
$342K +$317K +3,700 New
SCM
263
Sterling Capital Management
North Carolina
$340K -$1.57M -18,382 -83%
Canada Life
264
Canada Life
Manitoba, Canada
$337K +$685 +8 +0.2%
Neuberger Berman Group
265
Neuberger Berman Group
New York
$334K -$201K -2,347 -39%
TH
266
Timber Hill
Connecticut
$329K +$304K +3,553 New
Cambridge Investment Research Advisors
267
Cambridge Investment Research Advisors
Iowa
$324K -$164K -1,916 -35%
GT
268
Glenmede Trust
Pennsylvania
$305K -$12.3M -143,967 -98%
N
269
Natixis
France
$296K -$1.07M -12,465 -80%
Fuller & Thaler Asset Management
270
Fuller & Thaler Asset Management
California
$296K
MC
271
Moors & Cabot
Massachusetts
$291K +$270K +3,150 New
SSG
272
Summit Securities Group
New York
$287K +$265K +3,100 New
PAG
273
Private Advisor Group
New Jersey
$285K -$51.4K -600 -16%
CCA
274
Cobblestone Capital Advisors
New York
$276K -$4.51M -52,701 -95%
CCMH
275
Cornerstone Capital Management Holdings
New York
$268K -$2.17M -25,368 -90%

QCOR Hedge Fund Activity: Q2 2014 in Review

320 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in QUESTCOR PHARMA INC (QCOR) for Q2 2014, worth a combined $6.07B — up 50% from $4.06B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new QCOR positions and 79 closed out — a net gain of 7 holders — while 68 added to existing stakes and 142 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $378M. The largest seller was Fidelity Investments, cutting an estimated $306M.

  • 320 institutional investors held QUESTCOR PHARMA INC (QCOR) as of Q2 2014, up from 313 in Q1 2014.
  • Funds reported $6.07B of QUESTCOR PHARMA INC stock for Q2 2014, up 50% quarter-over-quarter.
  • 86 funds opened new QUESTCOR PHARMA INC positions in Q2 2014 and 79 closed out, a net change of +7 holders.
  • The largest QUESTCOR PHARMA INC buyer in Q2 2014 was Adage Capital Partners, an estimated $378M added.
  • The largest QUESTCOR PHARMA INC seller in Q2 2014 was Fidelity Investments, an estimated $306M sold.

Based on aggregated 13F filings for Q2 2014.